Asia-Pacific Skin Graft Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product (Autologous, Allogeneic, Xenogeneic, Prosthetic, and Isogeneic), Graft Thickness (Split-Thickness, Full-Thickness, and Composite Graft), Application (Burns, Extensive Wound, Skin Cancer, and Other Applications), Equipment (Dermatome, General Surgical Instruments, Consumables, and Others), and End User (Ambulatory Surgical Centers, Hospitals, and Dermatology Clinics)


No. of Pages: 100    |    Report Code: TIPRE00024546    |    Category: Life Sciences

Asia-Pacific Skin Graft Market
Buy Now

Market Introduction

Asia Pacific Skin Graft market comprises China, India, Japan, South Korea, Australia, and rest of Asia Pacific. In China, the growth of the market is attributed to rise in the number of cancer cases, rising emphasis on skin protection and development of new technologies for treatment of cancer. As per the report published in 2015, by American Cancer Society, in China, 4.3 million new cancer cases were diagnosed and more than 2.8 million deaths. Rising incidence of cancer has become one of the major economic concern for the country. On the other hand, growing geriatric population is expected to serve vital growth opportunities in coming year. The group of geriatric people are likely to diagnose with diabetes, and other wound through surgeries, fall downs and trauma and more. Among all these factors, diabetes is the primary factor leading to the maximum of diabetic foot ulcer. According to the International Diabetes Federation 2017, ~120 million people had diabetes in China. Additionally, according to the WHO, the diabetic population in China is expected to rise approximately 150 million by 2040. Moreover, the research studies and surveys reveal that in China, the average cost of hospitalization for diabetic foot ulcers (DFUs) is about US$ 2499.02 (i.e., 17,183 yuan). Thus, owing to the increasing incidences of diabetes, and increasing expenses to treat diabetic foot ulcer is likely to serve excellent growth opportunities for the market’s growth

The outbreak of the COVID-19 pandemic has come from China. The spread of infection has affected various Asian countries such as India, South Korea, Australia, Malaysia, Singapore, and others. The countries have reported maximum deaths and laboratory diagnosed positive patients. Amid the second wave of COVID-19, India is experiencing the highest number of cases with lack of healthcare infrastructure. Therefore, various businesses and economies have dramatically affected, resulting in crises. The major focus has been shifted to treat COVID-19 affected patients and the production of personal equipment products. On the other hand, Asian countries have a maximum number of burn cases. Countries such as India, Nepal, and Pakistan have ~ 1 million cases for burn wounds. According to the WHO, an estimated 180 000 deaths every year are caused by burns – the vast majority occur in low- and middle-income countries. In addition, in India, the State-run Victoria hospital affiliated to the Bangalore Medical College and Research Institute (BMCRI) was converted into a dedicated COVID-19 facility ever since the pandemic hit Karnataka in March, the functioning of the Mahabodhi Burns Ward in the hospital has not been hit. Despite the pandemic, the hospital continued to operate normally, following all COVID-19 precautions. With only one skin donation, the hospital was able to graft patches of skin from the patients themselves. Therefore, the outbreak of the COVID-19 pandemic is estimated to affect skin grafts negatively. It is estimated that it will continue to affect negatively in the coming few years.


Get more information on this report

Asia-Pacific Skin Graft Strategic Insights

Strategic insights for the Asia-Pacific Skin Graft provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-skin-graft-market-strategic-framework.webp
Get more information on this report

Asia-Pacific Skin Graft Report Scope

Report Attribute Details
Market size in 2021 US$ 181.81 Million
Market Size by 2028 US$ 316.80 Million
Global CAGR (2021 - 2028) 8.3%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Autologous
  • Allogeneic
  • Xenogeneic
  • Prosthetic
  • Isogeneic
By Graft Thickness
  • Split-Thickness
  • Full-Thickness
  • Composite Graft
By Application
  • Burns
  • Extensive Wound
  • Skin Cancer
  • Other Applications
By Equipment
  • Dermatome
  • General Surgical Instruments
  • Consumables
By End User
  • Ambulatory Surgical Centers
  • Hospitals
  • Dermatology Clinics
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • B. Braun Melsungen AG
  • Integra Life Sciences Corporation
  • MiMedx
  • Organogenesis Inc
  • Smith & Nephew
  • Zimmer Biomet
  • Get more information on this report

    Asia-Pacific Skin Graft Regional Insights

    The geographic scope of the Asia-Pacific Skin Graft refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-skin-graft-market-geography.webp
    Get more information on this report


    Market Overview and Dynamics

    The skin graft market in APAC is expected to grow from US$ 181.81 million in 2021 to US$ 316.80 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. Surge in number of burn injuries; major application areas of skin grafts include burns and skin infections. There has been a rise in the number of burns and deaths caused due to burns. Similarly, according to the World Health Organization (WHO) statistics published in 2018, more than 180,000 deaths occurred due to burns. Most burns are reported from low or medium-income countries and Southeast Asia. With the rise in number of burn injuries, the demand for skin grafts to replace the damaged skin patch has increased during recent years. As per the National Burn Repository (NBR) statistics, in 2016, around 486,000 burn injuries received medical treatment. Over 60% of the hospitalizations related to burn injuries were admitted to 128 burn centers. Also, the cost of treatment has increased worldwide. Thus, the increasing number of injuries has contributed significantly to the growing demand for skin graft treatments, which is expected to continue during the forecast period leveraging the market’s growth.

     

    Key Market Segments

    Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others

    .

    In 2020, the dermatome segment held the largest share of the market.

    Based on application, the market is segmented into burns, extensive wound, skin cancer, and others. In 2020, the burns segment held the largest share of the market

    .

    Based on end use

    r

    , the market is segmented into ambulatory surgical centers, hospitals and dermatology clinics. In 2020, the hospitals segment held the largest share of the market.

    Major Sources and Companies Listed

    A few major primary and secondary sources referred to for preparing this report on the skin graft market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are B. Braun Melsungen AG; Integra Life Sciences Corporation

    ;

    MiMedx; Organogenesis Inc; Smith & Nephew; Zimmer Biomet.

    Reasons to buy report

    • To understand the APAC skin graft market landscape and identify market segments that are most likely to guarantee a strong return
    • Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC Skin Graft Market
    • Efficiently plan M&A and partnership deals in APAC skin graft market by identifying market segments with the most promising probable sales
    • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC skin graft market
    • Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

     

     

    APAC SKIN GRAFT MARKET SEGMENTATION

     

    By Product

    • Autologous
    • Allogeneic
    • Xenogeneic
    • Prosthetic
    • Isogeneic

     

    By Graft Thickness

    • Split-Thickness
    • Full-Thickness
    • Composite Graft

     

    By Equipment

    • Dermatome
    • General Surgical Instruments
    • Consumables
    • Others

     By Application

    • Burns
    • Extensive Wound
    • Skin Cancer
    • Other Applications

    By End User

    • Hospitals
    • Ambulatory Surgical Centers
    • Dermatology Clinics

     

    By Country

    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of APAC

    Companies Mentioned

    • B. Braun Melsungen AG
    • Integra Life Sciences Corporation
    • MiMedx
    • Organogenesis Inc
    • Smith & Nephew
    • Zimmer Biomet
     

    The List of Companies - Asia-Pacific Skin Graft Market

    1. B. Braun Melsungen AG
    2. Integra Life Sciences Corporation
    3. MiMedx
    4. Organogenesis Inc
    5. Smith & Nephew
    6. Zimmer Biomet
    Frequently Asked Questions
    How big is the Asia-Pacific Skin Graft Market?

    The Asia-Pacific Skin Graft Market is valued at US$ 181.81 Million in 2021, it is projected to reach US$ 316.80 Million by 2028.

    What is the CAGR for Asia-Pacific Skin Graft Market by (2021 - 2028)?

    As per our report Asia-Pacific Skin Graft Market, the market size is valued at US$ 181.81 Million in 2021, projecting it to reach US$ 316.80 Million by 2028. This translates to a CAGR of approximately 8.3% during the forecast period.

    What segments are covered in this report?

    The Asia-Pacific Skin Graft Market report typically cover these key segments-

    • Product (Autologous, Allogeneic, Xenogeneic, Prosthetic, Isogeneic)
    • Graft Thickness (Split-Thickness, Full-Thickness, Composite Graft)
    • Application (Burns, Extensive Wound, Skin Cancer, Other Applications)
    • Equipment (Dermatome, General Surgical Instruments, Consumables)
    • End User (Ambulatory Surgical Centers, Hospitals, Dermatology Clinics)

    What is the historic period, base year, and forecast period taken for Asia-Pacific Skin Graft Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific Skin Graft Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia-Pacific Skin Graft Market?

    The Asia-Pacific Skin Graft Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • B. Braun Melsungen AG
  • Integra Life Sciences Corporation
  • MiMedx
  • Organogenesis Inc
  • Smith & Nephew
  • Zimmer Biomet
  • Who should buy this report?

    The Asia-Pacific Skin Graft Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia-Pacific Skin Graft Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now